Literature DB >> 23246488

Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin.

Qiang Sun1, Jianjun Zhang, Wei Cao, Xu Wang, Qin Xu, Ming Yan, Xiangbing Wu, Wantao Chen.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) is characterised by an elevated capacity for tumour invasion and lymph node metastasis and the cause remains to be determined. Recent studies suggest that microRNAs can regulate the evolution of malignant behaviours by regulating multiple target genes. In this study, we have first confirmed that miR-363 is down-regulated in HNSCC tissues with lymph node metastasis and cell lines with highly invasive capacity. We used bioinformatics, cellular and molecular methods to predict and prove that miR-363 directly targeted to podoplanin (PDPN) and caused up-regulation of PDPN in HNSCC. MSP assay showed that DNA promoter methylation was involved in silencing the miR-363 in HNSCC. Furthermore, we provided evidence to demonstrate that PDPN dysregulation caused by down-regulation of miR-363 contributes to HNSCC invasion and metastasis. These data reveal a key role of miR-363-PDPN in HNSCC metastasis and support biological and clinical links between miR-363-PDPN and HNSCC.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23246488     DOI: 10.1016/j.biocel.2012.12.004

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  41 in total

1.  microRNA-363 plays a tumor suppressive role in osteosarcoma by directly targeting MAP2K4.

Authors:  Xueqin Li; Xinsheng Liu; Jun Fang; Huazhuang Li; Jingchun Chen
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Transcriptional control of PAX4-regulated miR-144/451 modulates metastasis by suppressing ADAMs expression.

Authors:  J Zhang; X Qin; Q Sun; H Guo; X Wu; F Xie; Q Xu; M Yan; J Liu; Z Han; W Chen
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

3.  Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.

Authors:  Zhaofeng Chen; Xiaoguang Liu; Zenan Hu; Yuping Wang; Min Liu; Xiaojun Liu; Hailong Li; Rui Ji; Qinhong Guo; Yongning Zhou
Journal:  Oncol Lett       Date:  2015-05-06       Impact factor: 2.967

4.  Role of deregulated microRNAs in non-small cell lung cancer progression using fresh-frozen and formalin-fixed, paraffin-embedded samples.

Authors:  Yahong Wang; Jie Chen; Ziying Lin; Jun Cao; Haili Huang; Yun Jiang; Huijuan He; Lawei Yang; Nina Ren; Gang Liu
Journal:  Oncol Lett       Date:  2015-11-25       Impact factor: 2.967

Review 5.  Non-coding RNAs deregulation in oral squamous cell carcinoma: advances and challenges.

Authors:  T Yu; C Li; Z Wang; K Liu; C Xu; Q Yang; Y Tang; Y Wu
Journal:  Clin Transl Oncol       Date:  2015-09-14       Impact factor: 3.405

6.  MiR-363 sensitizes cisplatin-induced apoptosis targeting in Mcl-1 in breast cancer.

Authors:  Ruiguang Zhang; Yan Li; Xiaochuan Dong; Li Peng; Xiu Nie
Journal:  Med Oncol       Date:  2014-11-22       Impact factor: 3.064

7.  Hypermethylation of miR-203 in endometrial carcinomas.

Authors:  Yi-Wen Huang; Chieh-Ti Kuo; Jo-Hsin Chen; Paul J Goodfellow; Tim H-M Huang; Janet S Rader; Denise S Uyar
Journal:  Gynecol Oncol       Date:  2014-02-14       Impact factor: 5.482

8.  MicroRNA-363-3p Inhibits the Expression of Renal Fibrosis Markers in TGF-β1-Treated HK-2 Cells by Targeting TGF-β2.

Authors:  Xiangnan Dong; Yang Li; Rui Cao; Honglan Xu
Journal:  Biochem Genet       Date:  2021-02-25       Impact factor: 1.890

9.  Dysregulated miR-645 affects the proliferation and invasion of head and neck cancer cell.

Authors:  Qiang Sun; Shuai Chen; Xue Zhao; Ming Yan; Zheng Fang; Haibin Wang; Junfang Zhao; Minglei Sun; Xinguang Han; Wantao Chen; Xinming Li
Journal:  Cancer Cell Int       Date:  2015-09-17       Impact factor: 5.722

10.  REG4 is a transcriptional target of GATA6 and is essential for colorectal tumorigenesis.

Authors:  Yoshihiro Kawasaki; Kosuke Matsumura; Masaya Miyamoto; Shinnosuke Tsuji; Masumi Okuno; Sakiko Suda; Masaya Hiyoshi; Joji Kitayama; Tetsu Akiyama
Journal:  Sci Rep       Date:  2015-09-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.